We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Fetal Surgery Procedure Yields Landmark Results

By HospiMedica International staff writers
Posted on 23 Feb 2011
A new study demonstrates a clear benefit for babies who undergo in-utero repair of myelomeningocele to treat spina bifida, the most common birth defect in the central nervous system (CNS). More...


Researchers at Vanderbilt University Medical Center (Nashville, TN, USA), the University of California, San Francisco (UCSF; USA), and Children's Hospital of Philadelphia (CHOP; PA, USA) randomly assigned 183 eligible women participating in the management of myelomeningocele study (MOMS) to undergo either prenatal surgery before 26 weeks of gestation, or standard postnatal repair. The main study outcomes were a composite of fetal or neonatal death or the need for placement of a cerebrospinal fluid (CSF) shunt by the age of 12 months, and a composite of mental development and motor function at 30 months. The study was stopped for efficacy of prenatal surgery after the recruitment of 183 of a planned 200 patients

The researchers based on the study results on 158 patients whose children were evaluated at 12 months. The actual rates of shunt placement were 40% in the prenatal-surgery group and 82% in the postnatal-surgery group. Prenatal surgery also resulted in improvement in the composite score for mental development and motor function at 30 months, and in improvement in several secondary outcomes, including hindbrain herniation (Chiari Malformation) by 12 months and ambulation by 30 months. However, prenatal surgery was also associated with an increased risk of preterm delivery and uterine dehiscence at delivery. The study was published early online on February 9, 2011, in the New England Journal of Medicine (NEJM).

"Because mothers are willing to go to extraordinary lengths to help their babies, and bear significant risks, even to their own health, we needed compelling evidence that the procedure is beneficial and safe,” said study coauthor surgeon Kelly Bennett, MD, who performed the maternal portion of the surgery at Vanderbilt. "It is very satisfying to me that, with this new evidence, we can change our dialogue with families and offer the information they need to be able to make an informed decision.”

Spina bifida is a developmental birth defect caused by the incomplete closing of the embryonic neural tube due to lack of folic acid (folate). The layers of tissue and bone that normally cover and protect the spinal cord fail to close during development, leaving delicate nerves exposed to the intrauterine environment. Children are often left with severe disabilities, including paralysis below the waist and lifelong bladder and bowel problems. Nearly 90% of children with this disorder develop hydrocephalus, a fluid build-up within the brain, which requires surgical placement of a shunt to drain excess CSF, which, while necessary to save a child's life, can impact intellectual development.

Related Links:

Vanderbilt University Medical Center
University of California, San Francisco
Children's Hospital of Philadelphia



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.